Coca-Cola Europacific Partners
CCEP · NASDAQ
About CCEP
- Employees
- 39,000
- Headquarters
- Uxbridge, Middlesex
- Listed
- Nov 24, 1986
- Sector
- Consumer Staples
- Industry
- Beverages
- Website
- cocacolaep.com
CCEP key statistics
- Market cap
- 50.27B
- Price-earnings ratio
- 0.00
- Dividend yield
- 2.06%
- Average volume
- 1.69M
- Volume
- 2.34M
- Open price
- $112.82
- High today
- $113.51
- Low today
- $112.16
- 52 Week high
- $113.67
- 52 Week low
- $84.66
Coca-Cola Europacific Partners (CCEP) at a glance
Coca-Cola Europacific Partners (CCEP) last traded at $113.41, with a market cap of 50.27B, a price-to-earnings ratio of 0.00 and a dividend yield of 2.06%.
Today the stock has traded between $112.16 and $113.51. The current price is 1.1% above the day's low and 0.1% below its high.
Volume so far is 2.34M shares, above the average of 1.69M shares a day.
Over the past year Coca-Cola Europacific Partners has ranged from $84.66 to $113.67, and now sits 99% of the way up that range.
Coca-Cola Europacific Partners met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q4 FY18 it reported $0.54 per share against an estimate of $0.5455.
The average analyst price target is $112.89, 0.5% below the current price, from 7 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy57.1%
- Hold28.6%
- Sell14.3%
- Low
- $93.72
- Now
- $113.41
- High
- $126.00
CCEP earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 3.6% on average.
- Q1 FY17: reported $0.31 per share against an estimate of $0.2966
- Q2 FY17: reported $0.67 per share against an estimate of $0.6172
- Q3 FY17: reported $0.68 per share against an estimate of $0.6942
- Q4 FY17: reported $0.49 per share against an estimate of $0.4728
- Q1 FY18: reported $0.33 per share against an estimate of $0.3273
- Q2 FY18: reported $0.67 per share against an estimate of $0.6667
- Q3 FY18: reported $0.76 per share against an estimate of $0.7657
- Q4 FY18: reported $0.54 per share against an estimate of $0.5455
CCEP news
- Piero Cingari
Coca-Cola Europacific Reports H1 2026 Results: Full Earnings Call Transcript
- Press releaseACCESS Newswire
Coca-Cola Europacific Partners plc Announces Results for The Six Months Ended 3 July 2026
- Press releaseACCESS Newswire
Coca-Cola Europacific Partners plc Announces Q1 Trading Update & Interim Dividend Declaration
- Press releaseACCESS Newswire
Coca-Cola Europacific Partners plc Announces Notice of AGM
- Press releaseACCESS Newswire
Coca-Cola Europacific Partners plc Announces Annual Financial Report
- Press releaseACCESS Newswire
Coca-Cola Europacific Partners plc Announces Preliminary Unaudited Results Q4 & FY 2025
- Press releaseACCESS Newswire
Coca-Cola Europacific Partners plc Announces Q3 Trading Update & Interim Dividend Declaration
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.